Instituto de Investigación Sanitaria Galicia Sur (IISGS)
Centro de investigación
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublicacións en colaboración con investigadores/as de Instituto de Biomedicina de Sevilla (23)
2024
-
Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study
Clinical Microbiology and Infection
-
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Journal of Gastroenterology
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
The imperative for quality control programs in Monkeypox virus DNA testing by PCR: CIBERINFEC quality control
Journal of Medical Virology, Vol. 95, Núm. 11
2022
-
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
PLoS ONE, Vol. 17, Núm. 7 July
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project
Microbiology spectrum, Vol. 10, Núm. 4, pp. e0005122
2021
-
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Liver International, Vol. 41, Núm. 9, pp. 2076-2086
-
Forum COPD Working Group Consensus on the Diagnosis, Treatment and Follow-Up of COPD
Archivos de Bronconeumologia, Vol. 57, Núm. 9, pp. 596-599
-
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792
-
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252
2020
-
A Contemporary Picture of Enterococcal Endocarditis
Journal of the American College of Cardiology, Vol. 75, Núm. 5, pp. 482-494
-
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536
-
Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17–25) (Journal of Hepatology (2020) 73(1) (17–25), (S0168827820301276), (10.1016/j.jhep.2020.02.028))
Journal of Hepatology
-
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
Journal of Hepatology, Vol. 73, Núm. 1, pp. 17-25
-
Telephone Support for Copd Patients During COVID-19
Open Respiratory Archives, Vol. 2, Núm. 3, pp. 179-185
2019
-
Role of age and comorbidities in mortality of patients with infective endocarditis
European Journal of Internal Medicine, Vol. 64, pp. 63-71
2018
-
Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis
Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562
-
Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort
Journal of Viral Hepatitis, Vol. 25, Núm. 6, pp. 699-706